ES2139596T3 - Procedimiento para el diagnostico in vitro de anomalias cromosomicas relacionadas con la enfermedad cmt1a. - Google Patents

Procedimiento para el diagnostico in vitro de anomalias cromosomicas relacionadas con la enfermedad cmt1a.

Info

Publication number
ES2139596T3
ES2139596T3 ES92909895T ES92909895T ES2139596T3 ES 2139596 T3 ES2139596 T3 ES 2139596T3 ES 92909895 T ES92909895 T ES 92909895T ES 92909895 T ES92909895 T ES 92909895T ES 2139596 T3 ES2139596 T3 ES 2139596T3
Authority
ES
Spain
Prior art keywords
probes
chromosomic
procedure
vitro diagnosis
cmt1a disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92909895T
Other languages
English (en)
Inventor
Broeckhoven Christine Neur Van
Peter Neurog Lab B Raeymaekers
Jonghe Peter De
Jean-Jacques Neuropat L Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of ES2139596T3 publication Critical patent/ES2139596T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCESO PARA EL DIAGNOSTICO DE ANOMALIAS CROMOSOMALES SUSCEPTIBLE DE SER ASOCIADAS A LA ENFERMEDAD CMT1A. LA INVENCION TAMBIEN SE REFIERE A SONDAS CONCEBIDAS PARA SU USO EN ESTE PROCESO DE DIAGNOSTICO IN VITRO Y A KITS QUE CONTIENEN DICHAS SONDAS. LAS SONDAS DE LA INVENCION PUEDE CONTENER UNA SECUENCIA CONSTITUIDA DE APROXIMADAMENTE 15 NUCLEOTIDOS SUCESIVOS DE FRAGMENTO NOTI, CON EL FRAGMENTO NOTI QUE TIENE 1.2 X 106 PARES DE BASE Y QUE SE PUEDE OBTENER DIGIRIENDO ADN HUMANO DE PACIENTES CON NOTI, SEPARANDO LOS FRAGMENTOS RESULTANTES DE LA DIGESTION POR ELECTROFORESIS DE GEL DE CAMPO PULSADO E HIBRIDIZANDO LOS FRAGMENTOS RESULTANTES CON CUALQUIERA DE LAS SONDAS VA W409, EW401 O VAW412 O SUS DERIVADOS, EN APROXIMADAMENTE EL NUMERO TOTAL DE LOS NUCLEOTIDAS SUCESIVOS DEL FRAGMENTO NOTI. LAS ONDAS PERMITEN LA DETECCION DE LA DUPLICACION DE UNA PARTE DEL CROMOSOMA 17P.
ES92909895T 1991-05-07 1992-05-06 Procedimiento para el diagnostico in vitro de anomalias cromosomicas relacionadas con la enfermedad cmt1a. Expired - Lifetime ES2139596T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91401220A EP0512181A1 (en) 1991-05-07 1991-05-07 Process for the in vitro diagnosis of chromosomal anomalies liable to be correlated with CMT1A disease

Publications (1)

Publication Number Publication Date
ES2139596T3 true ES2139596T3 (es) 2000-02-16

Family

ID=8208565

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92909895T Expired - Lifetime ES2139596T3 (es) 1991-05-07 1992-05-06 Procedimiento para el diagnostico in vitro de anomalias cromosomicas relacionadas con la enfermedad cmt1a.

Country Status (10)

Country Link
US (1) US6110670A (es)
EP (2) EP0512181A1 (es)
AT (1) ATE186074T1 (es)
AU (1) AU1683192A (es)
CA (1) CA2102300A1 (es)
DE (1) DE69230221T2 (es)
DK (1) DK0584145T3 (es)
ES (1) ES2139596T3 (es)
GR (1) GR3032235T3 (es)
WO (1) WO1992019770A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225057B1 (en) * 1998-07-23 2001-05-01 Palleja, Zavier Estivell Duplications of human chromosome 15q24-25 and anxiety disorders, diagnostic methods for their detection
FR2808276B1 (fr) * 2000-04-26 2004-04-02 Renaud Nalin Procede d'extraction indirecte de l'adn d'organismes non cultivables et adn susceptible d'etre obtenu par ledit procede
CA2847458C (en) 2000-12-13 2019-11-12 Baylor College Of Medicine Defects in periaxin associated with myelinopathies
EP1720636A4 (en) * 2004-02-02 2012-06-20 Univ British Columbia SCODAPHORESIS AND METHOD AND DEVICES FOR MOVING AND CONCENTRATING PARTICLES
US8529744B2 (en) 2004-02-02 2013-09-10 Boreal Genomics Corp. Enrichment of nucleic acid targets
US9186685B2 (en) 2012-01-13 2015-11-17 The University Of British Columbia Multiple arm apparatus and methods for separation of particles
US10337054B2 (en) 2004-02-02 2019-07-02 Quantum-Si Incorporated Enrichment of nucleic acid targets
US8518228B2 (en) 2011-05-20 2013-08-27 The University Of British Columbia Systems and methods for enhanced SCODA
KR100642421B1 (ko) * 2004-07-07 2006-11-03 공주대학교 산학협력단 염색체 17ｐ11.2-ｐ12 지역의 중복 및 결실로 발병하는유전성 신경질환의 진단방법 및 진단키트
KR100613038B1 (ko) 2004-07-07 2006-08-16 공주대학교 산학협력단 염색체 17ｐ11.2-ｐ12 지역의 중복을 제외한 유전자돌연변이를 발병 원인으로 하는 ＣＭＴ 질환의 진단방법및 진단키트
CA2496294A1 (en) 2005-02-07 2006-08-07 The University Of British Columbia Apparatus and methods for concentrating and separating particles such as molecules
CA2713313A1 (en) 2008-02-01 2009-08-06 The University Of British Columbia Methods and apparatus for particle introduction and recovery
US8877028B2 (en) 2009-04-21 2014-11-04 The University Of British Columbia System and methods for detection of particles
WO2013166444A2 (en) 2012-05-04 2013-11-07 Boreal Genomics Corp. Biomarker analysis using scodaphoresis
US9340835B2 (en) 2013-03-15 2016-05-17 Boreal Genomics Corp. Method for separating homoduplexed and heteroduplexed nucleic acids
US11130986B2 (en) 2015-05-20 2021-09-28 Quantum-Si Incorporated Method for isolating target nucleic acid using heteroduplex binding proteins
WO2021086985A1 (en) 2019-10-29 2021-05-06 Quantum-Si Incorporated Peristaltic pumping of fluids and associated methods, systems, and devices

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306616A (en) * 1991-06-06 1994-04-26 Baylor College Of Medicine Molecular diagnosis of autosomal dominant charcot-marie-tooth disease
AU2226592A (en) * 1991-06-06 1993-01-08 Baylor College Of Medicine Molecular diagnosis of autosomal dominant charcot-marie-tooth disease

Also Published As

Publication number Publication date
AU1683192A (en) 1992-12-21
EP0584145B1 (en) 1999-10-27
DE69230221D1 (de) 1999-12-02
EP0584145A1 (en) 1994-03-02
US6110670A (en) 2000-08-29
DK0584145T3 (da) 2000-04-25
GR3032235T3 (en) 2000-04-27
DE69230221T2 (de) 2000-05-31
WO1992019770A3 (en) 1993-01-07
EP0512181A1 (en) 1992-11-11
ATE186074T1 (de) 1999-11-15
WO1992019770A2 (en) 1992-11-12
CA2102300A1 (en) 1992-11-08

Similar Documents

Publication Publication Date Title
NO981944D0 (no) Lipopolyaminer som transfeksjonsmidler samt farmas÷ytisk anvendelse derav
ES2096750T3 (es) Vectores retroviricos utiles para la terapia genica.
CY1109463T1 (el) Πεπτιδια kdr και εμβολια που τα περιλαμβανουν
CY1106974T1 (el) Πολυδυναμη θεραπεια για επιτελεση απωλειας βαρους και θεραπευτικη αντιμετωπιση της παχυσαρκιας
EA200000711A1 (ru) 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, СПОСОБ ПОЛУЧЕНИЯ ФАРМАЦЕВТИЧЕСКИХ ПРЕПАРАТОВ, СОДЕРЖАЩИХ ЭТИ 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, И ИХ ПРИМЕНЕНИЕ ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
AR010348A1 (es) Cetobenzamidas, su utilizacion y composicion farmeceutica que las contienen
CY1109367T1 (el) Συνθεσεις και μεθοδοι για ενισχυση της παροχης θεραπευτικων παραγοντων σε κυτταρα
DK0839154T3 (da) Biologiske aktive peptider og præparater samt anvendelse deraf
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
ES2131190T3 (es) Composicion que contiene efectores de circulacion mejorada y procedimiento de utilizacion de la indicada composicion.
IS4455A (is) Veiruefni og kirnisbrot tengd MS sjúkdómi sem nýta má til sjúkdómsgreiningar, hindrunar og lækningar
Wyburn-Mason Malignant Change Following Herpex Simplex
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
SE7905593L (sv) Acylderivat av karnitin och forfarande for framstellning derav
WO1992019770A3 (en) Process for the in vitro diagnosis of chromosomal anomalies correlated with cmt1a disease
ES2137353T3 (es) Nuevos derivados esteroides especificos del colon o del ileon.
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
FI945787A0 (fi) Sulfoniumsuoloja ja menetelmä niiden valmistamiseksi
DE59308082D1 (de) Neue sonde zur tumordiagnostik oder tumortherapie
FI893681A0 (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
GR1001151B (el) Νεα xρηση θειορεδοξινης
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
DK0465581T3 (da) Erythromycinderivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 584145

Country of ref document: ES